{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:59:32Z","timestamp":1780959572474,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1124\/jpet.102.044826","type":"journal-article","created":{"date-parts":[[2003,1,22]],"date-time":"2003-01-22T00:25:12Z","timestamp":1043195112000},"page":"818-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor"],"prefix":"10.1016","volume":"304","author":[{"given":"Shigeyuki","family":"Chaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayoko","family":"Suetake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketoshi","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.044826_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(99)00465-3","article-title":"Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.","volume":"378","author":"Adan","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.044826_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0306-4522(91)90393-3","article-title":"Central-type benzodiazepines inhibit release of \u03b1-melanocyte-stimulating hormone from the rat hypothalamus.","volume":"42","author":"Blasquez","year":"1991","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.102.044826_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nm741","article-title":"Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist.","volume":"8","author":"Borowsky","year":"2002","journal-title":"Nature Med"},{"key":"10.1124\/jpet.102.044826_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.102.044826_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0022-3565(25)12910-8","article-title":"The atypical neuroleptic profile of the glycine\/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents.","volume":"277","author":"Bristow","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.044826_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-2999(99)00120-X","article-title":"In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001.","volume":"371","author":"Chaki","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.044826_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0092-8674(00)80467-5","article-title":"Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides.","volume":"91","author":"Chen","year":"1997","journal-title":"Cell"},{"key":"10.1124\/jpet.102.044826_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0091-3057(90)90267-L","article-title":"Proconflict effect of ACTH 1\u201324: interaction with benzodiazepines.","volume":"36","author":"Corda","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.102.044826_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.","volume":"436","author":"Cryan","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.044826_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0196-9781(91)90189-V","article-title":"Alpha MSH-induced excessive grooming behavior involves a GABAergic mechanism.","volume":"12","author":"De Barioglio","year":"1991","journal-title":"Peptides"},{"key":"10.1124\/jpet.102.044826_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","article-title":"Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth.","volume":"73","author":"Detke","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.102.044826_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants.","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.102.044826_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1126\/science.216073","article-title":"Intracerebral adrenocorticotropic hormone mediates novelty-induced grooming in the rat.","volume":"203","author":"Dunn","year":"1979","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.102.044826_bib14","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure.","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.044826_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0091-3057(80)90154-9","article-title":"Intraventricular ACTH reduces social interaction in male rats.","volume":"12","author":"File","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.102.044826_bib16","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1016\/S0021-9258(18)53088-X","article-title":"Molecular cloning of a novel melanocortin receptor.","volume":"268","author":"Gantz","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.044826_bib17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1006\/bbrc.1994.1580","article-title":"Molecular cloning, expression and characterization of a fifth melanocortin receptor.","volume":"200","author":"Gantz","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.102.044826_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0196-9781(95)02092-6","article-title":"Behavioral effects of alpha-MSH and MCH after central administration in the female rat.","volume":"17","author":"Gonzalez","year":"1996","journal-title":"Peptides"},{"key":"10.1124\/jpet.102.044826_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02244080","article-title":"Anxiolytic effect in the elevated plus-maze of the NMDA receptor AP7 microinjected into the dorsal periaqueductal grey.","volume":"103","author":"Guimaraes","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.102.044826_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice.","volume":"88","author":"Huszar","year":"1997","journal-title":"Cell"},{"key":"10.1124\/jpet.102.044826_bib21","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1210\/endo.139.12.6352","article-title":"Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo.","volume":"139","author":"Kask","year":"1998","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.102.044826_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)29416-7","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters. II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram and clomipramine.","volume":"298","author":"Millan","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.044826_bib23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-3565(24)39023-8","article-title":"S18616, a highly potent spiroimidazoline agonist at \u03b12-adrenoceptors: II. Influence on monoaminergic transmission, motor function and anxiety in comparison with dexmedetomidine and clonidine.","volume":"295","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.044826_bib24","first-page":"1298","article-title":"Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.","volume":"8","author":"Mountjoy","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.102.044826_bib25","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(24)38220-5","article-title":"Receptor binding, behavioral and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.","volume":"289","author":"Okuyama","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.044826_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0031-6997(25)06673-6","article-title":"Physiology and pharmacology of corticotropin-releasing factor.","volume":"43","author":"Owen","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.102.044826_bib27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0196-9781(90)90009-T","article-title":"Effects of ACTH (1\u201324) and ACTH\/MSH (4\u201310) on isolation-induced distress vocalization in domestic chicks.","volume":"11","author":"Panksepp","year":"1990","journal-title":"Peptides"},{"key":"10.1124\/jpet.102.044826_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4088\/JCP.v60n0206","article-title":"A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.","volume":"60","author":"Pigott","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.102.044826_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioral despair in rats: a new model sensitive to antidepressant treatments.","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.044826_bib30","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.90.19.8856","article-title":"Identification of a receptor for \u03b3 melanocortin and other proopiomelanocortin peptides in the hypothalamus and limbic system.","volume":"90","author":"Roselli-Rehfuss","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.044826_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.bjp.0701804","article-title":"Discovery of novel melanocortin4 receptor selective MSH analogues.","volume":"124","author":"Schioth","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.044826_bib32","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0024-3205(01)01217-6","article-title":"Involvement of corticotropin-releasing factor subtype 1 receptor in the acquisition phase of learned helplessness in rats.","volume":"69","author":"Takamori","year":"2001","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.044826_bib33","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0024-3205(01)01279-6","article-title":"Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test.","volume":"69","author":"Takamori","year":"2001","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.044826_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(99)00045-X","article-title":"Selective melanocortin MC4 receptor blockage reduces immobilization stress-induced anorexia in rats.","volume":"369","author":"Vergoni","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.044826_bib35","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.bjp.0701750","article-title":"The role of central melanocortin receptors in the activation of the hypothalamus-pituitary-adrenal-axis and the induction of excessive grooming.","volume":"123","author":"Von Frijtag","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.044826_bib36","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1097\/00000539-200112000-00052","article-title":"Chronic blockade of melanocortin receptors alleviates allodynia in rats with neuropathic pain.","volume":"93","author":"Vrinten","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.102.044826_bib37","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1523\/JNEUROSCI.20-21-08131.2000","article-title":"Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats.","volume":"20","author":"Vrinten","year":"2000","journal-title":"J Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524361749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524361749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.044826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:38:36Z","timestamp":1740008316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524361749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0022356524361749"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.044826","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.044826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}